Schedule 13G ownership disclosure

Emergent BioSolutions Inc

Common Stock · CUSIP: 29089Q105

Event date: 2025-12-31

Filing-level shares
3,553,999
Percent of class
6.76%
  • The Vanguard Group

    Shares: 3,553,999 · Class: 6.76%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000102909-26-000130
Form type
SCHEDULE 13G/A
Filer
Emergent BioSolutions Inc.
CIK
CIK 1367644
Filed
Jan 30, 2026
Reporting period
Dec 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub